AI Driven Drug Discovery Summit

QP recently attended the AI Driven Drug Discovery Summit in Boston, taking in some groundbreaking discussions on how AI is helping to reframe the future of drug discovery and healthcare innovation. Ideas and insights shared throughout the summit reinforced the incredible pace of progress that is ongoing in the field.? ? One critical question from the summit: are the targets good enough? AI’s potential role in biological validation offers a transformative approach to both druggable and previously undruggable spaces, emphasizing the importance of building well-controlled, high-quality datasets.?? ? Equally fascinating is AI's potential in the clinical space, where early successes are highlighting the ability to accelerate projects to Phase 1 trials and promising applications for interpreting clinical data.? ? As companies continue to integrate #AI in their pipeline, it’s clear that progress hinges on collaboration and cross-functional teams—those capable not only of navigating data and computer science but also of integrating expertise from fields like biology and chemistry—emphasizing the critical need to dismantle silos within the industry to drive meaningful advancements.? ? ?? Thank you #AIDDD for convening such a diverse array of experts and topics, it was truly an informative and thought-provoking summit! Philipp Trepte #AIDrugDiscovery #AIDrivenDrugDiscovery?

Feeling extremely humbled and grateful to share that BioBox won the inaugural Innovation Incubator competition at the AI Driven Drug Discovery Summit! During this competition we were fortunate to share our vision and framework for knowledge management in drug discovery to an audience of scientists, executives, and investors in the pharmaceutical industry in an intimate environment. As an early stage startup in this space, getting exposure is critical to unlocking opportunities to prove your value. That is why I am so thankful to the judges and the organizers for this opportunity. Since this event, I am thrilled to share that we've opened new opportunities to collaborate with many cutting-edge biotechnology companies, including 4 of the top 20 pharma companies. Reflecting back on our humble beginnings as scientists and graduate students at the University of Toronto and The Hospital for Sick Children looking to build out a new way to organize biomedical knowledge. Gaining support from our thriving entrepreneurship ecosystem here in Toronto from organizations such as MaRS Discovery District, UTEST, University of Toronto. Finding investors like 2048 Ventures and Contrary capital who were willing to believe in us and our crazy idea. Through to our first customers like the incredible team at Flare Therapeutics. We are so thankful for your support. Lastly, none of this would have been possible without my incredible team Hamza Farooq, Julian Mazzitelli, and Lauren Phillips. I owe you the world. Proud of all we've accomplished. This is for you guys. Let's go build the future of knowledge management in biopharma research. ??

A breath of fresh air at the AI Driven Drug Discovery Summit speaking with some many organizations that are doing groundbreaking work with AI and ML to accelerate the delivery of new treatments. We are very proud at Vultr to enable this work that impacts lives so directly. Great to see Markandeya Korula, Aleks Shar, MBA, Jaeson Nicolopulos and Lora Kratchounova

?? This fab video of the #AI Driven Drug Discovery summit in Boston earlier this week gives an accurate impression of the event. ?? Great ideas for the future role of AI in drug discovery and current activity in this fast evolving technology, ?? Opportunities for networking and meeting lots of very innovative and ambitious people looking to improve drug discovery, ?? Good hospitality which really helps the whole event come together, and ??? Great speakers with real insight and passion for their work. ?? I also enjoyed spotting myself in the vid! Thanks Kisaco Research for a fascinating and fun event. HGF Limited #DrugDiscovery #Bioinformatics #AI #ArtificialIntelligence #Conference #Networking

???Exciting Highlights from the AI Driven Drug Discovery Summit! ?? Our #VPE Team Lead, Douglas McCloskey, represented BioMed X Institute with inspiring insights at the AI Driven Drug Discovery Summit in Boston from November 12-14! ??? He shared the latest advancements from his #VPE Team, which, in partnership with Sanofi, is pioneering research on the Next Generation Virtual Patient Engine to accelerate the clinical translation of drug candidates. He also engaged with top industry leaders on the future of AI-driven drug discovery, fostering insightful discussions on its transformative potential. Douglas also joined QIAGEN’s pre-day Knowledge Graph Insight Session, diving into the powerful role of knowledge graphs in modern biopharma research. ???? Here’s a quick recap of the summit highlights: ?? Virtual patients (sometimes referred to as DigitalTwins) have the potential to reduce #DrugDiscovery and #DrugDevelopment in the #Pharmaceutical industry time and cost while improving access to life changing treatments to underrepresented patient populations. ?? High quality (curated) biomedical #KnowledgeGraphs (such as the QIAGEN BKB-HD) are critical enablers to build virtual patients using knowledge-driven or data-driven in silico science. ?? #AI enabled agentic workflows can expedite manual tasks related to building knowledge graphs and can democratize access to virtual patient technologies. See results (link in the first comment) from our most recent #Hackathon (VPE) "Results for AI agents for life sciences". Thank you to everyone who connected with us at the summit! We’re thrilled to bring back valuable insights and continue driving innovation in clinical translation and drug development. ???? Douglas McCloskey | Kyle Nilson, PhD | Ted Johnson | Scott J Magin | SHU YAN | Venkatesh Moktali, PhD | Are you interested in how AI agents can revolutionize Pharma R&D by seamlessly communicating with PK/PD/QSP models and Biomedical Knowledge Graphs? ???? Don’t miss our upcoming webinar in collaboration with Code Ocean: AI Agents for Pharma R&D ?? Date: November, 26, 2024 ? Time: 6 pm Berlin / 12 pm EST / 9 am PT Register Now: AI Agents for Pharma R&D https://lnkd.in/eXZs5Gtr #BioMedX #AIDrugDiscovery #VirtualPatients #ClinicalTranslation #KnowledgeGraph #Biopharma #InnovationInBiotech #FutureOfMedicine #AIDDD

What an incredible 3 days we had in Boston this week at the AI Driven Drug Discovery Summit! ?? Leaders and innovators from across the industry came together to push boundaries, ignite collaboration, and unveil the future of drug discovery ?? ?? Here's a sneak peek of the energy, insights and innovation - stay tuned for the FULL highlights video ??... Thank you to everyone who joined us including our amazing speakers and sponsors! MilliporeSigma, Cradle, Fovus, FRONTEO USA, Deep Genomics, HGF Limited, IPA (ImmunoPrecise Antibodies), Vultr, QC Ware Corp., QIAGEN, ARIScience, Helical, Netabolics, ReSync Bio. #AIDDD #aidrivendrugdiscovery #aidrugdiscovery #drugdiscovery #drugdiscoveryevent #aievent

?? ????’???? ???????????????? ???? ???? ???? ????????????'?? ????-???????????? ???????? ?????????????????? ????????????!??? It's been an incredible experience connecting with leaders across biotech, pharma, and AI and exploring how advanced technology reshapes #drugdiscovery. The conversations around AI, machine learning, and high-performance computing (HPC) have been inspiring, and we’re excited to share how Fovus is helping accelerate these innovations with our AI-powered serverless HPC platform. If you’re attending the conference, be sure to stop by Booth #2 and say hello! We’d love to discuss how Fovus can streamline your R&D workflows, optimize computational resources, and dramatically reduce cloud costs. We're looking forward to more insightful sessions and meaningful connections. Let’s drive the future of drug discovery together! #AIDrivenDrugDiscovery #HPC #DrugDiscovery #AIinHealthcare #LifeSciences #Boston

Having an incredible mission makes our work lives so much more fulfilling. Today I had the pleasure of speaking with June Guo Vice President of AI & ML at Athos Therapeutics Inc at the AI Driven Drug Discovery Summit about how Vultr and Dell Technologies is accelerating the pace of discovery almost 10x with GPU infrastructure underlying Athos’ AI Squared platform. Developing Precision Medicine to address Crohn’s and IBS which impacts 6% of the population is much more meaningful than the next image of a cat wearing blue pajamas. #AIDDD

?? Day 1 of the AI Driven Drug Discovery Summit in Boston has officially kicked off! We're excited to dive into groundbreaking sessions on how AI is transforming the future of drug development. From predictive modeling to faster discoveries, the innovations are limitless! ??? If you've joined us, don't forget to share your highlights...?? #AIDDD #AIDrugDiscovery #AIDrivenDrugDiscovery

??The countdown is ON! Just one week to go until the AI Driven Drug Discovery Summit kicks off, and we couldn’t be more excited to share this journey with you! ?? Get ready to dive deep into groundbreaking discussions, innovations, and insights led by the best in the industry. Our stellar lineup of speakers includes some of the brightest minds in AI and drug discovery ?? Join us for transformative talks, powerful networking, and to be part of an event that’s driving the future of drug discovery. Register now: https://lnkd.in/eMxB9_EB We look forward to welcoming you in Boston next week! ?? Daniyal Hussain, Yu Qiu, Michelle Nyein, Jackie Hunter PhD DSc CBE FBPharmacolS FMedSci, Stef van Grieken, Peter Clark, PhD, Jacob Berlin, PhD, Mark Adams, Lu Zhang, Ari Allyn-Feuer, Ashwini Ghogare, PhD, Dirk Van Hyfte, Zachary Webel, Elena (Lena) Dolgikh, PhD, Ed Addison, Zhiyong (Sean) Xie, Arvind Rao, Zoran Krunic, Yang-Ming Zhu, Hayley Donnella, Hiroyoshi Toyoshiba, Simon Beaulah, Petrina Kamya, Ph.D., Rohit A., Ethan Pickering, Monica Y Wang, Ph.D., Claire Leurent PhD MBA, Duncan Ng, Sriram Chandrasekaran, Mani F., Z. Nevin Gerek Ince, Soujanya Bhumkar, Julian Hess, Charles W. O'Donnell, June Guo, Brendan Frey, Chirag Sachar, PhD, Lauris Kemp, Xia Ning, Aiden Aceves, Ph.D., Peter McLean, Elena Diez Cecilia, PhD, MBA, Fengbo Ren, Lana Gladstein. #AIDDD #aidrivendrugdiscovery #aidrugdiscovery